During the past decade, Reproductive Associates of Delaware conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Reproductive Associates of Delaware" #1 sponsor was "Ferring Pharmaceuticals" with 4 trials, followed by "Fertility Biotech AG" with 1 trials sponsored, "IBSA Institut Biochimique SA" with 1 trials sponsored, "Illumina, Inc." with 1 trials sponsored and "Nora Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Reproductive Associates of Delaware" #1 collaborator was "Genesis Genetics" with 1 trials as a collaborator and "Reprogenetics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Reproductive Associates of Delaware" are "Infertility" (5 trials), "Aneuploidy" (1 trials), "Infertility, Female" (1 trials), "Primary Amenorrhea With Hypogonadotropic Hypogonadism" (1 trials) and "Repeated IVF Failure" (1 trials). Many other conditions were trialed in "Reproductive Associates of Delaware" in a lesser frequency.

Most popular intervention types in "Reproductive Associates of Delaware" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Follitropin delta" (2 trials), "AFOLIA" (1 trials), "Gonadorelin acetate SC 15 μg/pulse as a fixed dose, administered via. OmniPod pump" (1 trials) and "Gonadorelin acetate SC 20 μg/pulse as a fixed dose, administered via. OmniPod pump" (1 trials). Other intervention names were less common.

The vast majority of trials in "Reproductive Associates of Delaware" are 8 trials for "Female" genders.

Currently, there are NaN active trials in "Reproductive Associates of Delaware". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Reproductive Associates of Delaware, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Reproductive Associates of Delaware, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".